Literature DB >> 7957676

Derivation of germline competent embryonic stem cells with a combination of interleukin-6 and soluble interleukin-6 receptor.

J Nichols1, I Chambers, A Smith.   

Abstract

In this report we document the derivation of pluripotential embryonic stem (ES) cells in the absence of a feeder layer by supplementation of culture media with either ciliary neurotrophic factor or oncostatin M, or with a combination of interleukin-6 (IL-6) plus soluble interleukin-6 receptor (sIL-6R). These factors all activate gp130-associated signaling processes, as does the previously characterized ES cell maintenance factor Differentiation Inhibiting Activity (Leukemia Inhibitory Factor). In particular, the IL-6/sIL-6R complex is thought to act exclusively through gp130. All ES cell lines derived using IL-6/sIL-6R contributed extensively to chimeras and were transmitted through the germline at high frequency. These findings point to a pivotal role for gp130 in ES cell propagation and may be relevant to attempts to derive ES cells from species other than mouse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957676     DOI: 10.1006/excr.1994.1338

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  19 in total

1.  Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.

Authors:  Christiane Stuhlmann-Laeisz; Sigrid Lang; Athena Chalaris; Paliga Krzysztof; Sudarman Enge; Jutta Eichler; Ursula Klingmüller; Michael Samuel; Matthias Ernst; Stefan Rose-John; Jürgen Scheller
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

2.  Development of a pluripotent ES-like cell line from Asian sea bass (Lates calcarifer)--an oviparous stem cell line mimicking viviparous ES cells.

Authors:  V Parameswaran; Ravi Shukla; Ramesh Bhonde; A S Sahul Hameed
Journal:  Mar Biotechnol (NY)       Date:  2007-08-18       Impact factor: 3.619

Review 3.  Human embryonic stem cells: an in vitro model to study mechanisms controlling pluripotency in early mammalian development.

Authors:  Ludovic Vallier; Roger A Pedersen
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 4.  Is IL-6 both a cytokine and a neurotrophic factor?

Authors:  J A Wagner
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

5.  Multivariate proteomic analysis of murine embryonic stem cell self-renewal versus differentiation signaling.

Authors:  Wendy Prudhomme; George Q Daley; Peter Zandstra; Douglas A Lauffenburger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

6.  Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism.

Authors:  Katie L Pricola; Nastaran Z Kuhn; Hana Haleem-Smith; Yingjie Song; Rocky S Tuan
Journal:  J Cell Biochem       Date:  2009-10-15       Impact factor: 4.429

7.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3.

Authors:  H Niwa; T Burdon; I Chambers; A Smith
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

8.  A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo.

Authors:  Dang Vinh Do; Jun Ueda; Daniel M Messerschmidt; Chanchao Lorthongpanich; Yi Zhou; Bo Feng; Guoji Guo; Peiyu J Lin; Md Zakir Hossain; Wenjun Zhang; Akira Moh; Qiang Wu; Paul Robson; Huck Hui Ng; Lorenz Poellinger; Barbara B Knowles; Davor Solter; Xin-Yuan Fu
Journal:  Genes Dev       Date:  2013-06-15       Impact factor: 11.361

9.  Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the non obese diabetic mouse.

Authors:  Timothy J Davies; Paul J Fairchild
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

Review 10.  Ubiquitin-mediated regulation of JAK-STAT signaling in embryonic stem cells.

Authors:  Shigetsugu Hatakeyama
Journal:  JAKSTAT       Date:  2012-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.